MAPK Signaling - Tie-2 - MEK - p38
The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
清除全部
- B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂
- B7784 AL 8697Target: p38Summary: 有效的p38α选择性抑制剂
- B6674 Anisomycin中文名: 茴香霉素Target: p38|JNK|SAPKSummary: JNK激动剂
- B1135 GDC-0623Target: MEKSummary: MEK1抑制剂
- B1267 RefametinibTarget: MEKSummary: MEK1/MEK2抑制剂
- B1621 TAK-733Target: MEKSummary: MEK变构位点抑制剂
- B1285 SB 203580 hydrochlorideTarget: p38Summary: p38-MAPK特异性抑制剂
- A8689 PD 169316Target: p38Summary: P38 MAPK抑制剂
- A8686 VX-745Target: p38Summary: P38α抑制剂
- A8374 AZD8330Target: MEKSummary: MEK 1/2抑制剂